Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis by Johnson, Bryce G, Dang, Lan T, Marsh, Graham, Roach, Allie M, Levine, Zebulon G, Monti, Anthony, Reyon, Deepak, Feigenbaum, Lionel, Duffield, Jeremy S

Get full text

TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease by Gomez, Ivan G, Roach, Allie M, Nakagawa, Naoki, Amatucci, Aldo, Johnson, Bryce G, Dunn, Kadeshia, Kelly, Mark C, Karaca, Gamze, Zheng, Timothy S, Szak, Suzanne, Peppiatt-Wildman, Claire M, Burkly, Linda C, Duffield, Jeremy S

Get full text

Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways by Gomez, Ivan G, MacKenna, Deidre A, Johnson, Bryce G, Kaimal, Vivek, Roach, Allie M, Ren, Shuyu, Nakagawa, Naoki, Xin, Cuiyan, Newitt, Rick, Pandya, Shweta, Xia, Tai-He, Liu, Xueqing, Borza, Dorin-Bogdan, Grafals, Monica, Shankland, Stuart J, Himmelfarb, Jonathan, Portilla, Didier, Liu, Shiguang, Chau, B Nelson, Duffield, Jeremy S

Get full text

Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells... by Bame, Eris, Tang, Hao, Burns, Jeremy C, Arefayene, Million, Michelsen, Klaus, Ma, Bin, Marx, Isaac, Prince, Robin, Roach, Allie M, Poreci, Urjana, Donaldson, Douglas, Cullen, Patrick, Casey, Fergal, Zhu, Jing, Carlile, Thomas M, Sangurdekar, Dipen, Zhang, Baohong, Trapa, Patrick, Santoro, Joseph, Muragan, Param, Pellerin, Alex, Rubino, Stephen, Gianni, Davide, Bajrami, Bekim, Peng, Xiaomei, Coppell, Alex, Riester, Katherine, Belachew, Shibeshih, Mehta, Devangi, Palte, Mike, Hopkins, Brian T, Scaramozza, Matthew, Franchimont, Nathalie, Mingueneau, Michael

Get full text

Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis by Hopkins, Brian T, Bame, Eris, Bajrami, Bekim, Black, Cheryl, Bohnert, Tonika, Boiselle, Carrie, Burdette, Doug, Burns, Jeremy C, Delva, Luisette, Donaldson, Douglas, Grater, Richard, Gu, Chungang, Hoemberger, Marc, Johnson, Josh, Kapadnis, Sudarshan, King, Kris, Lulla, Mukesh, Ma, Bin, Marx, Isaac, Magee, Tom, Meissner, Robert, Metrick, Claire M, Mingueneau, Michael, Murugan, Paramasivam, Otipoby, Kevin L, Polack, Evelyne, Poreci, Urjana, Prince, Robin, Roach, Allie M, Rowbottom, Chris, Santoro, Joseph C, Schroeder, Patricia, Tang, Hao, Tien, Eric, Zhang, Fengmei, Lyssikatos, Joseph

Get full text

Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease by Nakagawa, Naoki, Barron, Luke, Gomez, Ivan G, Johnson, Bryce G, Roach, Allie M, Kameoka, Sei, Jack, Richard M, Lupher, Jr, Mark L, Gharib, Sina A, Duffield, Jeremy S

Get full text

Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease by Nakagawa, Naoki, Barron, Luke, Gomez, Ivan G., Johnson, Bryce G., Roach, Allie M., Kameoka, Sei, Jack, Richard M., Lupher, Mark L., Gharib, Sina A., Duffield, Jeremy S.

Get full text

Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis by Johnson, Bryce G, Dang, Lan T, Marsh, Graham, Roach, Allie M, Levine, Zebulon G, Monti, Anthony, Reyon, Deepak, Feigenbaum, Lionel, Duffield, Jeremy S

Get full text